TDAC
TDAC 1-star rating from Upturn Advisory

Translational Development Acquisition Corp. Ordinary Shares (TDAC)

Translational Development Acquisition Corp. Ordinary Shares (TDAC) 1-star rating from Upturn Advisory
$10.46
Last Close (24-hour delay)
Profit since last BUY1.16%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 71 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/18/2025: TDAC (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit 1.16%
Avg. Invested days 71
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 5.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/18/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 219.95M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -
52 Weeks Range 10.00 - 10.28
Updated Date 05/1/2025
52 Weeks Range 10.00 - 10.28
Updated Date 05/1/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.03

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 220386003
Price to Sales(TTM) -
Enterprise Value 220386003
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding 17250000
Shares Floating 3032762
Shares Outstanding 17250000
Shares Floating 3032762
Percent Insiders -
Percent Institutions 7.54

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Translational Development Acquisition Corp. Ordinary Shares

Translational Development Acquisition Corp. Ordinary Shares(TDAC) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC) that was founded in 2021. Its primary purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. As a SPAC, it does not have its own operational history or products before a business combination is completed. Its evolution is tied to its ability to identify and acquire a target company.

Company business area logo Core Business Areas

  • SPAC Operations: As a SPAC, its core business area is identifying, negotiating, and completing a business combination with a private operating company. This involves raising capital through an initial public offering (IPO), identifying a suitable acquisition target, and then merging with that target, thereby taking the target company public.

leadership logo Leadership and Structure

Translational Development Acquisition Corp. is led by a management team typical of a SPAC. This usually includes a CEO, CFO, and a board of directors with experience in finance, mergers and acquisitions, and the relevant industry sectors. The specific individuals and their detailed backgrounds would be found in its SEC filings.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • SPAC IPO and Business Combination: The 'product' of a SPAC like Translational Development Acquisition Corp. is its ability to provide a route to public markets for a private company through a business combination. Market share is not applicable in a traditional sense for a SPAC; its success is measured by the successful completion of a merger with a high-value target company. Competitors are other SPACs vying for attractive acquisition targets.

Market Dynamics

industry overview logo Industry Overview

The SPAC industry experienced significant growth and subsequent contraction. SPACs offer a faster and sometimes more flexible alternative to traditional IPOs for companies seeking to go public. However, regulatory scrutiny and market volatility have impacted the industry.

Positioning

Translational Development Acquisition Corp.'s positioning is that of a financial vehicle seeking a target. Its competitive advantage lies in its management team's ability to identify promising companies and execute a successful merger. It competes with numerous other SPACs for viable acquisition targets and with traditional IPO routes.

Total Addressable Market (TAM)

The TAM for SPACs is the total value of private companies seeking to go public. While difficult to quantify precisely, it represents a significant portion of the global private equity and venture capital landscape. Translational Development Acquisition Corp. is positioned to target companies within specific sectors, as often indicated in its IPO prospectus, aiming to capture a portion of this TAM through its business combination.

Upturn SWOT Analysis

Strengths

  • Experienced management team (typical for SPACs)
  • Access to public capital markets for a target company
  • Flexibility in deal structure for business combinations

Weaknesses

  • Lack of operational history and revenue before a business combination
  • Dependence on identifying and successfully merging with a suitable target
  • Short time frame to complete a business combination before liquidation

Opportunities

  • Identifying undervalued private companies seeking public listing
  • Capitalizing on favorable market conditions for IPOs
  • Targeting specific growth sectors with high potential

Threats

  • Increased regulatory scrutiny of SPACs
  • Market volatility and economic downturns affecting target valuations
  • Competition from other SPACs and traditional IPOs
  • Failure to identify a suitable target within the mandated timeframe

Competitors and Market Share

Key competitor logo Key Competitors

  • Other SPACs seeking business combinations
  • Companies pursuing traditional IPOs

Competitive Landscape

Translational Development Acquisition Corp. competes with hundreds of other SPACs for attractive acquisition targets. Its advantages lie in the expertise of its management team and its ability to structure a compelling deal. Disadvantages include the time constraint and the intense competition in the SPAC market.

Growth Trajectory and Initiatives

Historical Growth: Not applicable in the traditional sense as it is a SPAC. Its 'growth' is defined by its ability to successfully complete a business combination.

Future Projections: Future projections are entirely dependent on the target company identified for the business combination. Analyst estimates would focus on the growth prospects of that target company post-merger.

Recent Initiatives: The primary recent initiative for any SPAC is the ongoing search for and negotiation with a potential business combination target.

Summary

Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC) focused on finding a target for a business combination. Its strength lies in its potential to take a private company public efficiently. However, it faces significant risks due to the competitive SPAC market, regulatory scrutiny, and the inherent uncertainty of identifying and completing a successful merger within its timeframe. Its future success and financial performance are entirely contingent on the outcome of its business combination efforts.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company SEC Filings (e.g., S-1, 10-K, 8-K)
  • Financial news and data providers (e.g., Bloomberg, Refinitiv, Yahoo Finance)
  • Industry analysis reports

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. SPACs are high-risk investments, and investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Information about SPACs can change rapidly, especially regarding potential business combinations. This JSON output reflects the state of the company as a SPAC, prior to any potential business combination.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Translational Development Acquisition Corp. Ordinary Shares

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2025-02-13
Chairman of the Board & CEO Mr. Michael M. B. Hoffman J.D.
Sector Financial Services
Industry Shell Companies
Full time employees -
Full time employees -

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.